Dermata Therapeutics, Inc.(DRMA)

Biotechnology · San Diego, CA

$1.13+0.02 (+1.80%)

Delayed quote: Oct 6, 2026, 11:29 AM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T15:32:41.612Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:32:41.612Z.

Quote observation: 2026-10-06T15:29:22.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -8,034,258
Quote market capitalization: 4,545,022

FMP input reference: 7afec7845e5c1de7d6a7da79415c7f2016586588c7dc262303e5dc1b6d25f1da

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

DRMA Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

DRMA Competitors' Operating Cash Flow Yield

DRMA

Dermata Therapeutics, Inc.

Current

Market Cap

$4.55M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGMS

Bio Green Med Solution, Inc.

vs DRMA

Market Cap

$4.69M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PMCB

PharmaCyte Biotech, Inc.

vs DRMA

Market Cap

$4.40M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CLGN

CollPlant Biotechnologies Ltd.

vs DRMA

Market Cap

$4.33M

Operating Cash Flow Yield

N/A

TTM Avg

3.14%

3Y Avg

3.14%

5Y Avg

3.14%

LEXX

Lexaria Bioscience Corp.

vs DRMA

Market Cap

$4.83M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIDX

20/20 Biolabs Inc.

vs DRMA

Market Cap

$4.20M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRI

GRI Bio, Inc.

vs DRMA

Market Cap

$4.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PCSA

Processa Pharmaceuticals, Inc.

vs DRMA

Market Cap

$4.12M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CALC

CalciMedica, Inc.

vs DRMA

Market Cap

$4.94M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ERNA

Ernexa Therapeutics Inc.

vs DRMA

Market Cap

$4.08M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Dermata Therapeutics, Inc. (DRMA)	$4.55M	N/A	N/A	N/A	N/A
Bio Green Med Solution, Inc. (BGMS)vs ›	$4.69M	N/A	N/A	N/A	N/A
PharmaCyte Biotech, Inc. (PMCB)vs ›	$4.40M	N/A	N/A	N/A	N/A
CollPlant Biotechnologies Ltd. (CLGN)vs ›	$4.33M	N/A	3.14%	3.14%	3.14%
Lexaria Bioscience Corp. (LEXX)vs ›	$4.83M	N/A	N/A	N/A	N/A
20/20 Biolabs Inc. (AIDX)vs ›	$4.20M	N/A	N/A	N/A	N/A
GRI Bio, Inc. (GRI)vs ›	$4.11M	N/A	N/A	N/A	N/A
Processa Pharmaceuticals, Inc. (PCSA)vs ›	$4.12M	N/A	N/A	N/A	N/A
CalciMedica, Inc. (CALC)vs ›	$4.94M	N/A	N/A	N/A	N/A
Ernexa Therapeutics Inc. (ERNA)vs ›	$4.08M	N/A	N/A	N/A	N/A

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

DRMA Operating Cash Flow Yield Metrics

DRMA Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics